{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:47:51Z","timestamp":1786121271525,"version":"build-2736575974"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) and Hashimoto thyroiditis (HT) are endocrine disorders; when they co-exist, they exacerbate each other\u2019s serious consequences. Literature is scarce on these important diseases. This meta-analysis aimed to assess the prevalence of HT in both patients with PCOS and control subjects, as well as insulin resistance (IR) and lipid profile in patients with PCOS with and without HT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Embase, Web of Science, and Google Scholar from inception to February 2026 using combinations of keywords and MeSH terms related to polycystic ovary syndrome, Hashimoto thyroiditis, autoimmune thyroid disease, insulin resistance, and metabolic outcomes. We retrieved 209 articles, of which 38 full texts were screened, and 22 studies were included in the meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HT was higher in patients with PCOS compared to control subjects (OR\u00a0=\u00a02.69, 95% CI: 1.63 to 4.42), and women with PCOS and HT exhibited higher HOMA-IR than women with PCOS alone (MD = \u22120.92, 95% CI: \u22121.50 to \u22120.35). However, the TC, LDL, HDL, and TG were similar in patients with PCOS with and without HT (MD = \u22120.61, 95% CI: \u22121.40 to 0.18; MD = \u22120.49, 95% CI: \u22121.69 to 0.72; MD = 0.01, 95% CI: \u22120.09 to 0.07; and MD = \u22120.06, 95% CI: \u22120.35 to 0.23, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HT was more prevalent among women with PCOS than in controls. Women with PCOS and concomitant HT had higher IR than women with PCOS alone. However, the TC, LDL, HDL, and TG were similar in patients with PCOS with and without HT. Prospective studies with long follow-up are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1809000","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:22:21Z","timestamp":1786076541000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The crosstalk between polycystic ovary syndrome and Hashimoto thyroiditis: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Yazeed","family":"Albalawi","sequence":"first","affiliation":[{"name":"Obstetrics and Gynecology, Faculty of Medicine, University of Tabuk","place":["Tabuk, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyder","family":"Mirghani","sequence":"additional","affiliation":[{"name":"Internal Medicine and Endocrinology, Faculty of Medicine, University of Tabuk","place":["Tabuk, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-024-07607-x","article-title":"Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis","volume":"310","author":"Salari","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review","volume":"13","author":"Deswal","year":"2020","journal-title":"J Hum Reprod Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192214914","article-title":"Polycystic ovarian syndrome (PCOS): does the challenge end at conception","volume":"19","author":"Mirza","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph21030354","article-title":"Prevalence and diagnosis of PCOS using electronic health records: a scoping review and a database analysis","volume":"21","author":"Atiomo","year":"2024","journal-title":"Int J Environ Res Public Health"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100494","article-title":"Changes in the prevalence of polycystic ovary syndrome in China over the past decade","volume":"25","author":"Yang","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4071735","article-title":"Polycystic ovary syndrome may be an autoimmune disorder","volume":"2016","author":"Mobeen","year":"2016","journal-title":"Sci (Cairo)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-023-01261-5","article-title":"Thyroid peroxidase antibodies in infertile women with polycystic ovary syndrome","volume":"30","author":"Tran","year":"2023","journal-title":"Reprod Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1020709","article-title":"Global prevalence and epidemiological trends of Hashimoto's thyroiditis in adults: a systematic review and meta-analysis","volume":"10","author":"Hu","year":"2022","journal-title":"Front Public Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.606620","article-title":"Genetic susceptibility to joint occurrence of polycystic ovary syndrome and Hashimoto's thyroiditis: how far is our understanding","volume":"12","author":"Zeber-Lubecka","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02404-4","article-title":"Thyroid autoimmunity in different phenotypes of polycystic ovary syndrome: a single-center experience","volume":"47","author":"Benelli","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1211231","article-title":"The interplay of oxidative stress and immune dysfunction in Hashimoto's thyroiditis and polycystic ovary syndrome: a comprehensive review","volume":"14","author":"Bat\u00f3g","year":"2023","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12902-021-00706-9","article-title":"Hashimoto's thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to anti-M\u00fcllerian hormone levels","volume":"21","author":"Serin","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00440","article-title":"Ovarian reserve and serum concentration of thyroid peroxidase antibodies in euthyroid women with different polycystic ovary syndrome phenotypes","volume":"11","author":"Adamska","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.17954","article-title":"Detection of thyroid autoimmunity markers in euthyroid women with polycystic ovary syndrome: a case-control study from Syria","volume":"12","author":"Al-Saab","year":"2014","journal-title":"Int J Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3109\/07435800.2015.1015730","article-title":"High prevalence of Hashimoto's thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role","volume":"40","author":"Arduc","year":"2015","journal-title":"Endocr Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/0974-1208.178636","article-title":"Endocrinal and autoimmune linkage: evidences from a controlled study of subjects with polycystic ovarian syndrome","volume":"9","author":"Arora","year":"2016","journal-title":"J Hum Reprod Sci"},{"key":"B17","article-title":"Alta frecuencia de trastornos tiroideos en el s\u0131ndrome de ovario poliqu ' \u0131stico [High ' frequency of thyroid abnormalities in polycystic ovary syndrome","volume":"75","author":"Calvar","year":"2015","journal-title":"Med (B Aires)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0504-7","article-title":"Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome","volume":"49","author":"Duran","year":"2015","journal-title":"Endocrine"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-1012","article-title":"High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case-control study","volume":"162","author":"Ganie","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2013.03.003","article-title":"High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome","volume":"169","author":"Garelli","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17072422","article-title":"Increased risk of polycystic ovary syndrome and it's comorbidities in women with autoimmune thyroid disease","volume":"17","author":"Ho","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"684","DOI":"10.21037\/atm-19-4763","article-title":"Hashimoto's thyroiditis might increase polycystic ovary syndrome and associated comorbidities risks in Asia","volume":"8","author":"Ho","year":"2020","journal-title":"Ann Transl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1500363","article-title":"High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome","volume":"150","author":"Janssen","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-011-2040-5","article-title":"Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome","volume":"285","author":"Kachuei","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4274\/jtgga.2016.0217","article-title":"Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome","volume":"18","author":"Karak\u00f6se","year":"2017","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/14647273.2019.1709668","article-title":"Thyroid autoimmunity markers in women with polycystic ovary syndrome and controls","volume":"25","author":"Kim","year":"2022","journal-title":"Hum Fertil (Camb)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/09513590.2014.958990","article-title":"Polycystic ovary syndrome and chronic autoimmune thyroiditis","volume":"31","author":"Novais Jde","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2014.062","article-title":"The prevalence of non organ specific and thyroid autoimmunity in patients with polycystic ovary syndrome","volume":"159","author":"Petrikova","year":"2015","journal-title":"BioMed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.109714","article-title":"Thyroid disorders in polycystic ovarian syndrome subjects: a tertiary hospital based cross-sectional study from Eastern India","volume":"17","author":"Sinha","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.5603\/GP.a2021.0238","article-title":"The prevalence of autoimmune thyroiditis in adolescent girls with polycystic ovary syndrome","volume":"93","author":"Skrzynska","year":"2022","journal-title":"Ginekol Pol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2067087","article-title":"Subclinical hypothyroidism in PCOS: impact on presentation, insulin resistance, and cardiovascular risk","volume":"2016","author":"Yu","year":"2016","journal-title":"BioMed Res Int"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033205","article-title":"Assessment of glucose and lipid metabolism in patients with polycystic ovary syndrome with and without Hashimoto's thyroiditis","volume":"102","author":"Jia","year":"2023","journal-title":"Med (Baltimore)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S300015","article-title":"A comparative study on insulin secretion, insulin resistance and thyroid function in patients with polycystic ovary syndrome with and without Hashimoto's thyroiditis","volume":"14","author":"Zhao","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1159\/000479371","article-title":"An International Consortium Update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0309","article-title":"Association between PCOS and autoimmune thyroid disease: a systematic review and meta-analysis","volume":"7","author":"Romitti","year":"2018","journal-title":"Endocr Connect"},{"key":"B38","article-title":"The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis","volume":"6","author":"Du","year":"2013","journal-title":"Int J Clin Exp Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1025267","article-title":"Correlation between Hashimoto's thyroiditis and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"13","author":"Hu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B40","article-title":"Je syndr\u00f3m polycystick\u00fdch ov\u00e1ri\u00ed asociovan\u00fd s autoimunitnou tyreoidit\u00eddou? [Is polycystic ovary syndrome associated with autoimmune thyroiditis","volume":"58","author":"Petr\u00edkov\u00e1","year":"2012","journal-title":"Vnitr Lek"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2016.431","article-title":"Is subclinical hypothyroidism in patients with polycytic ovary syndrome associated with BMI","volume":"12","author":"Yasar","year":"2016","journal-title":"Acta Endocrinol (Buchar)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-023-02200-x","article-title":"Analysis of the effect of Hashimoto's thyroiditis and insulin resistance on ovarian volume in patients with polycystic ovary syndrome","volume":"23","author":"Gencer","year":"2023","journal-title":"BMC Womens Health"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084110","article-title":"Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism","volume":"23","author":"Armanini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2022.103628","article-title":"Systemic and ovarian inflammation in women with polycystic ovary syndrome","volume":"151","author":"Zhai","year":"2022","journal-title":"J Reprod Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11681","article-title":"Metabolic, hormonal, immunologic, and genetic factors associated with the incidence of thyroid disorders in polycystic ovarian syndrome patients","volume":"12","author":"Singh","year":"2020","journal-title":"Cureus"},{"key":"B46","article-title":"Thyroid disorders in polycystic ovary syndrome","volume":"21","author":"Kowalczyk","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1530\/EJE-14-0295","article-title":"Mechanisms in endocrinology: thyroid and polycystic ovary syndrome","volume":"172","author":"Gaber\u0161\u010dek","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218191","article-title":"Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome","volume":"21","author":"Qu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-021-00721-z","article-title":"Thyroid function, sex hormones and sexual function: a Mendelian randomization study","volume":"36","author":"Kjaergaard","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3897\/folmed.65.e75390","article-title":"Serum levels of leptin and adiponectin in patients with autoimmune Hashimoto's thyroiditis","volume":"65","author":"Tomov","year":"2023","journal-title":"Folia Med (Plovdiv)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60101648","article-title":"Age-related changes in insulin resistance and muscle mass: Clinical implications in obese older adults","volume":"60","author":"Rizvi","year":"2024","journal-title":"Med (Kaunas)"},{"key":"B52","first-page":"699","article-title":"Body mass index versus waist circumference in predicting insulin resistance in infertile women with polycystic ovary syndrome","volume":"32","author":"Ishrat","year":"2023","journal-title":"Mymensingh Med J"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00265","article-title":"Autoimmune disease in women: Endocrine transition and risk across the lifespan","volume":"10","author":"Desai","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-025-08121-4","article-title":"Temporal trends in the prevalence of polycystic ovary syndrome in China from 1990 to 2021, and projections until 2036: a comparison with Japan, Asia, and global level","volume":"312","author":"Wang","year":"2025","journal-title":"Arch Gynecol Obstet"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1809000\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:22:22Z","timestamp":1786076542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1809000\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":54,"alternative-id":["10.3389\/fendo.2026.1809000"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1809000","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"article-number":"1809000"}}